Early cancer detection in a large American Cancer Society cohort study: Retrospective analysis of methylated DNA biomarkers | Synapse
April 15, 2026
Early cancer detection in a large American Cancer Society cohort study: Retrospective analysis of methylated DNA biomarkers
Key Points
This research aims to evaluate the effectiveness of methylated DNA biomarkers for early cancer detection.
Conducted a retrospective analysis of a large cohort from the American Cancer Society.
Assessed detection rates of cancer signals as lead time changes.
Evaluated the implications of annual screening intervals based on average lead time.
Detection rates of cancer signals improved as lead time approached clinical diagnosis.
The average lead time was found to be around one year, supporting the need for annual screenings.
Abstract
Cancer signal detection rates change rapidly as lead time approaches clinical diagnosis. The average lead time of approximately 1 year supports annual screening intervals.